Clinical Predictors of Severe Toxicity in Patients Treated with Combination Chemotherapy with Irinotecan and/or Oxaliplatin for Metastatic Colorectal Cancer: A Single Center Experience
Keyword(s):
2009 ◽
Vol 8
(2)
◽
pp. 148-152
◽
2005 ◽
Vol 35
(9)
◽
pp. 531-535
◽
Cetuximab single-agent activity in refractory metastatic colorectal cancer: Single-center experience
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3703-3703
◽
Keyword(s):